Ross Moat

Insider Reports History

Location
Hamilton, Bermuda
Signature
/s/ Aaron Young, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ross Moat:

Company Role Class Num Shares Value Price $ Report Date Ownership
Kiniksa Pharmaceuticals International, plc CHIEF CORP. & COMM. OFFICER Performance Share Unit 5,225 $351,467 $17.88 01 May 2025 Direct
Kiniksa Pharmaceuticals International, plc CHIEF CORP. & COMM. OFFICER Class A Ordinary Share 9,415 $332,443 $35.31 04 Sep 2025 Direct
Kiniksa Pharmaceuticals International, plc CHIEF CORP. & COMM. OFFICER Share Option 39,364 01 Sep 2025 Direct
Kiniksa Pharmaceuticals International, plc CHIEF CORP. & COMM. OFFICER Performance Share Option 8,303 01 May 2025 Direct
Kiniksa Pharmaceuticals International, plc CHIEF CORP. & COMM. OFFICER Restricted Share Unit 0 02 Sep 2025 Direct

Insider Reports Filed by Ross Moat

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KNSA Kiniksa Pharmaceuticals International, plc 04 Sep 2025 1 -$124,397 4 CHIEF CORP. & COMM. OFFICER 08 Sep 2025, 16:37
KNSA Kiniksa Pharmaceuticals International, plc 01 Sep 2025 12 -$110,897 4 CHIEF CORP. & COMM. OFFICER 03 Sep 2025, 16:49
KNSA Kiniksa Pharmaceuticals International, plc 03 Jun 2025 3 -$432,398 4 CHIEF COMMERCIAL OFFICER 05 Jun 2025, 16:46
KNSA Kiniksa Pharmaceuticals International, plc 01 May 2025 10 -$103,649 4 CHIEF COMMERCIAL OFFICER 05 May 2025, 16:54
KNSA Kiniksa Pharmaceuticals International, plc 29 Apr 2025 18 -$1,091,449 4 CHIEF COMMERCIAL OFFICER 01 May 2025, 18:26
KNSA Kiniksa Pharmaceuticals International, plc 21 Apr 2025 1 -$370,475 4 CHIEF COMMERCIAL OFFICER 23 Apr 2025, 16:44
KNSA Kiniksa Pharmaceuticals International, plc 07 Apr 2025 3 -$14,744 4 CHIEF COMMERCIAL OFFICER 09 Apr 2025, 16:42
KNSA Kiniksa Pharmaceuticals International, plc 01 Apr 2025 9 -$21,422 4 CHIEF COMMERCIAL OFFICER 03 Apr 2025, 17:06
KNSA Kiniksa Pharmaceuticals International, plc 16 Mar 2025 4 +$11,286 4 CHIEF COMMERCIAL OFFICER 19 Mar 2025, 17:52
KNSA Kiniksa Pharmaceuticals International, plc 15 Jul 2024 18 -$1,082,170 4 CHIEF COMMERCIAL OFFICER 04 Sep 2024, 20:42
KNSA Kiniksa Pharmaceuticals, Ltd. 04 Apr 2024 6 -$24,219 4 CHIEF COMMERCIAL OFFICER 08 Apr 2024, 17:19
KNSA Kiniksa Pharmaceuticals, Ltd. 01 Apr 2024 3 -$17,336 4 CHIEF COMMERCIAL OFFICER 03 Apr 2024, 17:20
KNSA Kiniksa Pharmaceuticals, Ltd. 15 Jul 2023 9 -$30,067 4 CHIEF COMMERCIAL OFFICER 06 Sep 2023, 20:07
KNSA Kiniksa Pharmaceuticals, Ltd. 10 Apr 2023 3 -$14,491 4 CHIEF COMMERCIAL OFFICER 11 Apr 2023, 17:06
KNSA Kiniksa Pharmaceuticals, Ltd. 01 Apr 2023 2 $0 4 CHIEF COMMERCIAL OFFICER 03 Apr 2023, 16:30
KNSA Kiniksa Pharmaceuticals, Ltd. 15 Jan 2023 7 -$1,571 4 CHIEF COMMERCIAL OFFICER 20 Mar 2023, 17:19
KNSA Kiniksa Pharmaceuticals, Ltd. 01 Sep 2022 6 -$2,999 4 CHIEF COMMERCIAL OFFICER 06 Sep 2022, 16:12
KNSA Kiniksa Pharmaceuticals, Ltd. 07 Apr 2022 2 $0 4 CHIEF COMMERCIAL OFFICER 11 Apr 2022, 16:30
KNSA Kiniksa Pharmaceuticals, Ltd. 21 Mar 2022 3 -$13,615 4 CHIEF COMMERCIAL OFFICER 23 Mar 2022, 16:30
KNSA Kiniksa Pharmaceuticals, Ltd. 02 Sep 2021 2 $0 4 ARCALYST General Manager 07 Sep 2021, 17:16
KNSA Kiniksa Pharmaceuticals, Ltd. 15 Jul 2021 5 +$20,442 4 Chief Commercial Officer 18 Mar 2022, 16:39